跳至主要内容
临床试验/ACTRN12620000652976
ACTRN12620000652976撤回未知

Protocol for an effectiveness-implementation hybrid trial to assess the effectiveness of implementing applied muscle tension during plasma apheresis on reducing the incidence of syncope and presyncope symptoms: a cluster randomised step-wedged study

Australian Red Cross Lifeblood0 个研究点目标入组 13,000 人开始时间: 2020年6月5日最近更新:
适应症

试验速览

阶段
未知
状态
撤回
入组人数
13,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1. Donor centres with minimum attendance of 54 plasma donors per week
  • 2. Donor centres using the Aurora machine used as standard plasmapheresis practice for a minimum of 4 weeks to 3 months depending on guidance from the Clinical Hypervigilance team and the Donor Services Leadership Team
  • PARTCIPANTS
  • 1. Eligible for plasma donation as per the current ‘Guidelines for the Selection of Blood Donors’ (GSBD)
  • 2. Plasmapheresis donation
  • 3. Consent to participate in study (survey component only)

排除标准

  • 1. Plasma only donor centres
  • 2. Donor mobile units (DMUs) and demountable mobile units
  • 3. Participation in another research study (R&D or Marketing) that may interfere with donor recruitment and the outcomes under investigation
  • 4. Donor Services Leadership Team consider the donor centre not appropriate for participation (e.g. centre undergoing renovations, relocation)
  • PARTICIPANTS
  • 1. Donors not donating plasma by apheresis (e.g., whole blood, platelets, sample only)
  • 2. Australian Red Cross Lifeblood staff members

研究者

相似试验